Japan Personalized Cancer Vaccine Market Size & Outlook
Related Markets
Japan personalized cancer vaccine market highlights
- The Japan personalized cancer vaccine market generated a revenue of USD 11.0 million in 2024 and is expected to reach USD 65.7 million by 2030.
- The Japan market is expected to grow at a CAGR of 41.3% from 2025 to 2030.
- In terms of segment, dendritic cell was the largest revenue generating type in 2024.
- Dendritic Cell is the most lucrative type segment registering the fastest growth during the forecast period.
Personalized cancer vaccine market data book summary
| Market revenue in 2024 | USD 11.0 million |
| Market revenue in 2030 | USD 65.7 million |
| Growth rate | 41.3% (CAGR from 2025 to 2030) |
| Largest segment | Dendritic cell |
| Fastest growing segment | Dendritic Cell |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dendritic Cell |
| Key market players worldwide | Dendreon, Gritstone bio, CureVac NV Ordinary Shares, Stemirna, Elicio Therapeutics, Evaxion Biotech, Imugene, Nouscom |
Other key industry trends
- In terms of revenue, Japan accounted for 5.3% of the global personalized cancer vaccine market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China personalized cancer vaccine market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 128.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Personalized Cancer Vaccine Market Scope
Personalized Cancer Vaccine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Nouscom | View profile | 11-50 | Basel, Basel-Stadt, Switzerland, Europe | https://nouscom.com/ |
| Imugene | View profile | 51-100 | Sydney, New South Wales, Australia, Oceania | https://www.imugene.com/ |
| Evaxion Biotech | View profile | 11-50 | Copenhagen, Hovedstaden, Denmark, Europe | http://evaxion-biotech.com/ |
| Elicio Therapeutics | View profile | 11-50 | Cambridge, Massachusetts, United States, North America | https://elicio.com |
| Stemirna | View profile | 11-50 | Beijing, Beijing, China, Asia | http://www.stemirna.com/ |
| Gritstone bio | View profile | 101-250 | Emeryville, California, United States, North America | https://gritstonebio.com |
| Dendreon | View profile | 1001-5000 | Seattle, Washington, United States, North America | http://www.dendreon.com/ |
| CureVac NV Ordinary Shares | View profile | 1100 | Friedrich-Miescher-Strasse 15, Tubingen, BW, Germany, 72076 | https://www.curevac.com |
Japan personalized cancer vaccine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized cancer vaccine market will help companies and investors design strategic landscapes.
Dendritic cell was the largest segment with a revenue share of 105.45% in 2024. Horizon Databook has segmented the Japan personalized cancer vaccine market based on dendritic cell covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Japan personalized cancer vaccine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan personalized cancer vaccine market databook
-
Our clientele includes a mix of personalized cancer vaccine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan personalized cancer vaccine market , including forecasts for subscribers. This country databook contains high-level insights into Japan personalized cancer vaccine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan Type - Personalized Cancer Vaccine Market size, 2024 - 2030 (US$M)
Japan Personalized Cancer Vaccine Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
